Anika Therapeutics (ANIK) Operating Income Growth (5y) (2015 - 2026)
Anika Therapeutics (ANIK) Operating Income Growth (5y) (2015 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Haleon | 89.15 Bn | 87.28 Bn | - |
| 2 | Teva Pharmaceutical Industries | 35.89 Bn | 32.15 Bn | 1.97 Bn |
| 3 | Zoetis | 32.49 Bn | 30.55 Bn | 1.62 Bn |
| 4 | Takeda Pharmaceutical | 27.56 Bn | 23.50 Bn | 4.39 Bn |
| 5 | United Therapeutics | 23.20 Bn | 21.05 Bn | 648.10 Mn |
| 6 | RedHill Biopharma | 21.76 Bn | 21.76 Bn | - |
| 7 | Viatris | 20.28 Bn | 18.48 Bn | 1.16 Bn |
| 8 | Neurocrine Biosciences | 17.74 Bn | 16.43 Bn | 800.70 Mn |
| 9 | Elanco Animal Health | 12.58 Bn | 12.15 Bn | 785.00 Mn |
| 10 | Anika Therapeutics | 203.37 Mn | 136.58 Mn | 19.00 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -44.79% |
| Dec 31, 2025 | 15.28% |
| Sep 30, 2025 | 16.42% |
| Jun 30, 2025 | 15.21% |
| Mar 31, 2025 | -21.09% |
| Dec 31, 2024 | -16.51% |
| Sep 30, 2024 | -14.95% |
| Jun 30, 2024 | -16.56% |
| Mar 31, 2024 | -19.70% |
| Dec 31, 2023 | 20.40% |
| Sep 30, 2023 | -23.69% |
| Jun 30, 2023 | -18.36% |
| Mar 31, 2023 | -9.89% |
| Dec 31, 2022 | 11.01% |
| Sep 30, 2022 | -20.73% |
| Jun 30, 2022 | -16.98% |
| Mar 31, 2022 | -19.57% |
| Dec 31, 2021 | -22.12% |
| Sep 30, 2021 | -37.55% |
| Jun 30, 2021 | -7.38% |